Exchange: NASDAQ·Updated 10:54 AM EDT
GOSS logo

GOSS Gossamer Bio Inc

$11.12
$0.57
(4.88%)
Today
EarningsNov 4
Mkt Cap$71.43M
Vol77,410.00

About GOSS

Gossamer Bio, Inc. engages in discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. Its primary product candidate, GB001, is intended for the treatment of moderate-to-severe eosinophilic asthma and other allergic conditions. The company was founded by Faheem Hasnain and Sheila Gujrathi on October 26, 2015 and is headquartered in San Diego, CA.
40

Bearish Sentiment

How do you feel about GOSS?

Advertisement|Remove ads.